{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-021779","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.447000+00:00","generated_at":"2026-06-12T09:57:22.867913+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"National Research reports Q2 2023 diluted EPS $0.29, down from $0.33 YoY; new sales up 53%","bullets":["Diluted EPS $0.29 for Q2 2023 vs $0.33 for Q2 2022, a 12% decrease.","New sales increased 53% compared to Q2 2022.","Human Understanding Program adopted by 39 healthcare organizations through June 30.","Capital allocation: $4.2M innovation/growth, $3.0M dividends, $1.8M share repurchases in Q2.","Operating margins improved in Q2 2023 compared to Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-021779","json":"https://secwatch.observer/filing/0001437749-23-021779.json","markdown":"https://secwatch.observer/filing/0001437749-23-021779.md","text":"https://secwatch.observer/filing/0001437749-23-021779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774923021779/0001437749-23-021779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774923021779/nrc20230802_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T09:57:22.867913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2170a1ea15e99de80d0145e79d1378a2a8997519","claim":"NRC HEALTH reported second quarter ended June 30, 2023 results: EPS $0.29.","evidence_excerpt":"Diluted earnings per share decreased to $0.29 for the quarter ended June 30, 2023, from diluted earnings per share of $0.33 for the quarter ended June 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774923021779/0001437749-23-021779-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"EPS","value":"$0.29"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}